Banks Bet Big on Mutual Funds
Your daily dose of business news
🗞️ Banks Park Big Money with Mutual Funds
Amid soft credit demand, Indian banks are increasingly parking surplus funds with mutual funds, driving their investments in such schemes up 91% YoY to ₹1.19 lakh crore. Most of the money is flowing into liquid and money market funds, helping banks earn higher short-term yields.
💬 Expert Take:
“Banks are tactically shifting capital to mutual funds for liquidity and quick returns, especially when lending opportunities are limited.”
— Meera Krishnan, Fixed Income Strategist
🗞️ NBFC-MFIs Write Off ₹2,440 Crore in Q4
Five listed NBFC-MFIs have written off bad loans worth ₹2,440 crore in the Jan–Mar quarter, aiming to clean their books and prepare for growth. These write-offs are seen as signs of balance sheet repair and sector revival.
💬 Expert Take:
“This is a proactive cleansing strategy. With credit quality improving, NBFCs are getting ready for the next phase of growth.”
— Sandeep Dutta, Financial Sector Analyst
🗞️ PSU Banks Plan Unified Debt Recovery Platform
Public sector banks, including SBI, PNB and BoB, are working on a common platform for recovering small-value loans. The goal is to streamline efforts, particularly in recovering dues from MSMEs and retail borrowers with exposure below ₹5 crore.
💬 Expert Take:
“A unified recovery channel enhances operational efficiency and improves recovery rates, especially for smaller NPAs.”
— Akhil Sharma, Banking Consultant
🗞️ Europe’s Inflation Drops to 1.9%, Focus Shifts to Tariffs
Inflation in the eurozone has fallen to 1.9%, easing cost-of-living concerns. However, worries now turn to global trade tensions, especially with potential tariffs from a Trump-led U.S. administration looming over the horizon.
🗞️ Yes Bank to Raise ₹16,000 Crore via Equity, Debt
The board of Yes Bank has approved raising ₹16,000 crore through a mix of equity and debt instruments. The move is intended to boost capital buffers and support future expansion.
🗞️ Zydus Signs Cancer Therapy Deal with Agenus
Zydus Lifesciences has inked a licensing deal with U.S.-based Agenus Inc. for developing and commercializing a novel immunotherapy for cancer, expanding its oncology footprint globally.
🗞️ Hyundai Exits Ola Electric, Sells ₹690 Cr Stake to Kia
Hyundai Motor has exited its investment in Ola Electric by selling ₹690 crore worth of shares to Kia Corp via a bulk deal. The transaction reshapes alliances within India’s rapidly growing EV ecosystem.
🗞️ Nvidia-Backed Nebius Raises $1 Billion in Debt
Nebius, a cloud services firm backed by Nvidia, has raised $1 billion via convertible debt to scale up operations. The funds will fuel product development and expansion in the high-demand AI and cloud infrastructure space.
Market Updates:
📉 Sensex: 80,737.51 ▼ -636.24 (-0.78%)
📉 Nifty 50: 24,542.50 ▼ -174.10 (-0.70%)
💵 USD/INR: ₹83.12 ▼ -0.11 (-0.13%)
🛢️ Brent Crude: $81.10 ▲ +$0.80 (+1.00%)
🪙 Bitcoin: $105,530.00 ▲ +$586.00 (+0.56%)
🪙 Gold (24K): ₹9,687/gram ▲ +₹33